Y

01558

YiChang HEC ChangJiang Pharmaceu…

This stock has been delisted.
News
Press Releases
Financial Reports
Profile
Same Industry
Name/Symbol
Change%
Price

Y

YiChang HEC ChangJiang Pharmaceutical

01558

-0.25%
15.880

A

AMGEN-T

04332

0.00%

凱萊英

06821

+2.24%
93.500

藥明康德

02359

+0.81%
124.500

海螺創業

00586

0.00%
11.060

國藥控股

01099

+0.35%
17.210

白雲山

00874

-0.45%
15.360

麗珠醫藥

01513

-1.28%
26.320

上海醫藥

02607

+0.79%
11.550

復星醫藥

02196

-0.06%
16.230

康哲藥業

00867

+0.95%
10.650

06600

--

W

Wuxi Biologics (Cayman)

02269

+0.99%
32.740

中國同輻

01763

0.00%
17.800

神威藥業

02877

-0.70%
8.470

聯邦制藥

03933

+0.23%
8.680

康臣葯業

01681

+2.27%
14.420

3

3SBio

01530

-1.88%
15.680

山東新華製藥股份

00719

+0.34%
5.960

同仁堂國藥

03613

-0.14%
6.970

華潤醫藥

03320

-0.21%
4.730

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.